Tolerx
American biotech company focused on immune tolerance therapies.
Last updated November 4, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Tolerx is an American biotech company focused on developing immune tolerance therapies for autoimmune and inflammatory diseases. Its pipeline includes otelixizumab for type 1 diabetes.
Products and positioning
A biotechnology company focused on immunotolerance therapies
Cite this profile: Cite the canonical profile. /brand-wiki/tolerx · Editorial policy · How profiles are compiled